Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

LIDOCAINE AND PRILOCAI

Active
SPE2DP-26-T-4204Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract specifies the procurement of LidoProcaine and PriLocaine Periodontal Gel, marketed as ORAQIX at a 2.5%/2.5% concentration, supplied in dental cartridges containing 1.7 grams of microemulsion gel each. Each cartridge is individually blister-packaged with a single-use sterile blunt-tipped applicator, and units are distributed in cartons of 20, making the unit of issue a package. The product has a fixed 36-month shelf life with a minimum requirement of 31 months remaining at the time of receipt by the first government activity, and it must be stored at controlled room temperature between 20°C and 25°C. As a regulated medical device and drug under FDA oversight, all labeling, marking, and packaging must strictly conform to Medical Marking Standard No. 1, superseding MIL-STD-129, and all packaging must meet commercial standards designed to protect against damage and ensure safe, cost-effective delivery via common carriers. The item is identified by NSN 6505-01-656-9640 and manufacturer part number NDC66312-0110-20, supplied by Dentsply Sirona Inc. The order quantity is 4 packages, with delivery required within 20 days FOB destination, no variance allowed in quantity, and inspection and acceptance occurring at the destination. The contract references applicable DLA technical and quality requirements and mandates compliance with hazardous materials shipping standards. The solicitation number is SPE2DP-26-T-4204, with a response deadline of July 27, 2026, and the required delivery date is July 22, 2026.

General Info

Procurement of 4 cartons of ORAQIX dental gel, NSN 6505-01-656-9640, delivery by July 22, 2026.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

424210 - Drugs and Druggists' Sundries Merchant WholesalersView NAICS

Place of Performance

US

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-4204 Medical Supply Chain Pharm FSA

PDFrfq

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS
Contacts

Full Description

Show more
LIDOCAINE AND PRILOCAINE,PERIODONTAL GEL
LIDOCAINE AND PRILOCAINE, PERIODONTAL GEL.
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
RX ONLY. UNIT OF ISSUE IS A PACKAGE CONTAINING 20 CARTRIDGES. ORAQIX
(LIDOCAINE AND PRILOCAINE PERIODONTAL GEL,) 2.5%/2.5% IS A
MICROEMULSION.. ORAQIX (LIDOCAINE AND PRILOCAINE PERIODONTAL GEL),
2.5%/2.5%, IS SUPPLIED IN DENTAL CARTRIDGES THAT PROVIDE 1.7G GEL.
INDIVIDUALLY BLISTER-PACKAGED CARTRIDGES OF ORAQIX ARE DISTRIBUTED IN A
CARTON OF 20.. EACH INDIVIDUAL BLISTER PACKAGE ALSO CONTAINS A STERILE
BLUNT-TIPPED APPLICATOR. EACH BLUNT-TIPPED APPLICATOR IS FOR SINGLE USE
ONLY. TOTAL SHELF LIFE IS 36 MONTHS.. THERE SHALL BE A MINIMUM OF 31
MONTHS OF REMAINING SHELF LIFE AT THE TIME OF RECEIPT BY THE FIRST
GOVERNMENT ACTIVITY.. STORE AT 20° TO 25°C (68° TO 77°F) [SEE USP
CONTROLLED ROOM TEMPERATURE]. LABELING AND MARKING MUST IN ACCORDANCE
WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013. 08/02/2016
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil.
SPE2DP-26-T-4204
SECTION B
MMS NO. 1 IS ALSO AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
SHALL BE MARKED IAW THE LATEST EDITION OF
THE MEDICAL MARKING STANDARD NO. 1.
MMS NO. 1 IS AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
DENTSPLY SIRONA INC 0KSX4 P/N NDC66312-0110-20
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017543398 0001 PG 4.000
NSN/MATERIAL:6505016569640
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
QUP:001 PRES MTHD:ZZ CLNG/DRY:Z PRESV MAT:ZZ
WRAP MAT:ZZ CUSH/DUNN MAT:ZZ CUSH/DUNN THKNESS:Z
UNIT CONT:ZZ OPI:M
INTRMDTE CONT:ZZ INTRMDTE CONT QTY:ZZZ
PACK CODE:Z PACKING LEVEL: B
MARKING SHALL BE IN ACCORDANCE WITH MIL-STD-129.
SPECIAL MARKING CODE:ZZ -ZZ Special Requirements
IP025: PACKAGING, MARKING, AND SHIPPING OF HAZARDOUS MATERIALS
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
SPE2DP-26-T-4204
SECTION B
PR: 7017543398 PRLI: 0001 CONT’D
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
FM5270
FM5270 18 MDSS SGSM
CP 011 81 98 938 1111 EXT 634 4572
KADENA AB BLDG 3154
KADENA AB OKINAWA 904 0200
JP
MEDICAL AIR BRIDGE WEST. FOR ELIGIBLE ITEMS: SD0379. CARDINAL HEALTH, 4551 EAST PHILADELPHIA ST ONTARIO,
CA (TEXT IN ENHANCEMENT)
M/F: (TCN) FM527061980198
RDD:
PROJ: TP 3
SUPP ADD: YNONE SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 12
DIC: A01 DIST: ADV: 2A FC: 6B
Need Ship Date:00/00/0000 Original Required Delivery Date:07/22/2026
SPE2DP-26-T-4204 NSN/Part Number: 6505-01-656-9640 Quantity: 4 PG Purchase Request: 7017543398QTY: 4 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 424210
New
DIBBS
Pharmaceutical Supply – Amoxicillin and Clavulanate Potassium (NSN 6505017138324)The contract pertains to the supply and delivery of one unit of Amoxicillin and Clavulanate Potassium, identified by NSN 6505017138324, to Fort Hood, Texas, under the delivery order requirements of the Defense Logistics Agency. This is a subcontract issued under the Department of Defense, with the NAICS code 424210, indicating it falls within Wholesale Trade of Pharmaceuticals and Pharmacy Supplies. The item is intended for military use and must comply with all DLA procurement standards for pharmaceuticals, including specifications for potency, purity, and packaging. Delivery is scheduled to meet operational readiness needs at the specified military installation. The contract was posted on July 20, 2026, and is linked to the active DLA award SPE2DP26F7754 under the master contract SPE2DX25D9900. While the solicitation number is not provided, the transaction is managed through the DIBBS system, and all terms are governed under federal supply chain protocols for defense medical materiel. No specific set-aside status or small business designation is indicated. The place of performance is restricted to Fort Hood, Texas, ensuring the medication supports the health and readiness of service members stationed there. No point of contact information is listed, indicating standard DLA procedural handling without direct bidder outreach.
Defense Logistics Agency

POSTED

about 20 hours ago

DEADLINE

N/A
View Details
NAICS: 424210
New
DIBBS
Medical Product Distribution & FOB Destination LogisticsThe contract entails the end-to-end logistical execution of shipping, tracking, and final delivery of pharmaceutical products to a forward-deployed naval vessel using a fleet post office address, ensuring uninterrupted medical supply continuity in operational environments. This includes full compliance with U.S. export control regulations, proper documentation for international shipments, and rigorous verification of receipt through authenticated proof of delivery mechanisms to guarantee accountability and regulatory adherence throughout the supply chain. The work is performed under a subcontract agreement governed by the Defense Logistics Agency under the Department of Defense, with the North American Industry Classification System code 424210 indicating wholesale medical and pharmaceutical product distribution as the primary activity. All logistics operations must align with military requirements for secure, time-sensitive delivery to remote and mobile naval units, where failure to deliver could impact mission readiness and personnel health. The shipment path integrates commercial courier services with military logistics protocols, requiring coordination across multiple jurisdictions and adherence to strict pharmaceutical handling standards. While specific geographic details for the place of performance are not provided, the delivery destination is invariably a U.S. Navy vessel operating in contested or overseas theaters, necessitating flexible, responsive, and classified-compliant transport solutions. The contract’s UI link references official DLA award records, confirming its formal status within the federal procurement system under contract number SPE2D926F7459.
Defense Logistics Agency

POSTED

about 20 hours ago

DEADLINE

N/A
View Details
NAICS: 424210
New
DIBBS
SUNSCREEN PREPARATIONThe contract is for the procurement of a sunscreen preparation with a sun protection factor (SPF) of 50, formulated with 4.5% titanium dioxide and 4% zinc oxide, designed for topical application. The product is sweat and water-resistant for 80 minutes, hypoallergenic, oil-free, PABA-free, biodegradable, and intended for outdoor use. Each package contains 24 individual 3-ounce tubes, and the total shelf life is 24 months with a mandatory minimum of 21 months remaining at the time of receipt by the first government activity. Storage must occur between 15°C and 30°C (59°F to 86°F) in a cool, dry environment. The item is regulated by the FDA and classified as a Type I (Code M) medical device with a non-extendable shelf life under RS016. The unit of issue is a package (PG), and deliveries are required in two separate quantities: three packages under CLIN 0001 and one package under CLIN 0002, both under the same NSN 6505016579247. Delivery is FOB destination within five days of order, with no tolerance for quantity variance. All shipments must be traceable by commercial carriers; parcel post is prohibited. Packaging must comply with DLA's packaging requirements, including medical marking standard number one (MMS NO. 1), which supersedes MIL-STD-129 for medical items. Packaging must ensure protection from damage and secure transport at the lowest applicable rate, with palletization aligned to RP001. The product must be marked in accordance with MMS NO. 1 and shipped to designated military locations in Fort Bragg, North Carolina, and North Stonington, Connecticut. The contract includes stringent compliance obligations under multiple federal and defense regulations. Hazardous material classification is determined by FED-STD-313; if classified as hazardous, packaging must comply with TQ requirement IP025; otherwise, commercial packaging per ASTM D3951 applies, though DLA's Master List of Technical and Quality Requirements takes absolute precedence. Cybersecurity requirements mandate adherence to 252.204-7012 for safeguarding covered defense information and reporting cyber incidents. The contractor must also comply with clauses on combating trafficking in persons, employment eligibility verification, sustainable products, and prohibition of hexavalent chromium
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

2 days ago

DEADLINE

in 6 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency